Clinical trial registry record

Metformin Effects on Metabolic, Vitamin B12, Iron, Erythropoietin, and Hematological Parameters in Women With PCOS

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 4 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 31, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07793838
Last registry update
August 31, 2026
Status
Completed
Phase
Phase 4
Sponsor
Jerash Private University
Enrollment
400
Countries
Jordan
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 4
Study design
RANDOMIZED · PARALLEL · TREATMENT · SINGLE
Evidence population
Human clinical study registration
Participants
400
Population
FEMALE · 18 Years to 40 Years
Duration
2025-08-01 to 2026-08-01
Intervention
Metformin; Matching Placebo
Comparator
Matching Placebo Group
Outcomes measured
Longitudinal change in serum iron — Baseline, 3 months, and 6 months; Longitudinal change in total iron-binding capacity — Baseline, 3 months, and 6 months; Longitudinal change in serum ferritin — Baseline, 3 months, and 6 months; Longitudinal change in transferrin saturation — Baseline, 3 months, and 6 months; Longitudinal change in serum vitamin B12 — Baseline, 3 months, and 6 months.; Longitudinal change in erythropoietin — Baseline, 3 months, and 6 months.; Longitudinal change in hemoglobin — Baseline, 3 months, and 6 months.; Longitudinal change in hematocrit — Baseline, 3 months, and 6 months.; Longitudinal change in red blood cell count — Baseline, 3 months, and 6 months.; Longitudinal change in mean corpuscular volume — Baseline, 3 months, and 6 months.; Longitudinal change in mean corpuscular hemoglobin — Baseline, 3 months, and 6 months.; Longitudinal change in mean corpuscular hemoglobin concentration — Baseline, 3 months, and 6 months.; Longitudinal change in red cell distribution width — Baseline, 3 months, and 6 months.; Longitudinal change in white blood cell count — Baseline, 3 months, and 6 months.; Longitudinal change in lymphocyte count — Baseline, 3 months, and 6 months.; Longitudinal change in neutrophil count — Baseline, 3 months, and 6 months.; Longitudinal change in eosinophil count — Baseline, 3 months, and 6 months.; Longitudinal change in basophil count — Baseline, 3 months, and 6 months.; Longitudinal change in monocyte count — Baseline, 3 months, and 6 months.; Longitudinal change in platelet count — Baseline, 3 months, and 6 months.
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 4A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Metformin · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

metformin
Read the original source →Export JSON